Regulation of DNA replication fork genes by 17β-estradiol

Molecular Endocrinology

Volumn 16, Issue 6, 2002, Pages 1215-1229

  Lobenhofer, Edward K ^a,b   Bennett, Lee ^a   Louann Cable, P ^a   Li, Leping ^b   Bushel, Pierre R ^c   Afshari, Cynthia A ^b  

^a Gene Interference Group   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c Biostatistics Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN RECEPTOR; GROWTH FACTOR; RNA; ALCOHOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA;

ARTICLE; BREAST CARCINOMA; CELL CYCLE; CELL CYCLE S PHASE; CELL LEVEL; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DNA REPLICATION; DNA REPLICATION FORK; DNA TRANSCRIPTION; DOSE TIME EFFECT RELATION; ESTROGEN ACTIVITY; GENE CONTROL; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; MITOGENESIS; MITOGENICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIVISION; CELL SURVIVAL; DNA REPLICATION; ESTRADIOL; ETHANOL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035989216     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.16.6.1215     Document Type: Article

References (64)

1. On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment, with illustrative cases
2. Cell cycle control by steroid hormones
3. Transcription activation by estrogen and progesterone receptors
4. Mechanism of estrogen activation of c-myc oncogene expression
5. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor
6. Transcriptional activation of genes by 17 β-estradiol through estrogen receptor-Sp1 interactions
7. Estrogen receptor pathways to AP-1
8. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
9. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
10. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis
11. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells
12. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1
13. Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cells
14. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: Analysis of estrogen's effect on progesterone receptor synthesis and degradation
15. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells
16. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen
17. Modulation of cathepsin-D and pS2 protein levels in human breast cancer cell lines
18. Estrogen regulation of cell cycle progression in breast cancer cells
19. The Rb/E2F pathway and cancer
20. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints
21. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis
22. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis
23. Gonadotropin-releasing hormone receptor-coupled gene network organization
24. Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling
25. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer
26. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland
27. Effects of estrogen on global gene expression: Identification of novel targets of estrogen action
28. Identification of estrogen-induced genes downregulated by AhR agonists in MCF-7 breast cancer cells using suppression subtractive hybridization
29. Microarrays and toxicology: The advent of toxicogenomics
30. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7
31. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture
32. The role of estrogens on the proliferation of human breast tumor cells (MCF-7)
33. Cloning of a novel receptor expressed in rat prostate and ovary
34. Transcription activation by the human estrogen receptor subtype β (ER β) studied with ER β and ER α receptor chimeras
35. A comparison of transcriptional activation by ER α and ER β
36. Differences in protein kinase C and estrogen receptor α, β expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants
37. Expression and regulation of estrogen receptor β in human breast tumors and cell lines
38. Use of a cDNA microarray to analyse gene expression patterns in human cancer
39. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
40. Ratio-based decisions and the quantitative analysis of cDNA microarray images
41. MAPS: A microarray project system for gene expression experiment information and data validation
42. Cluster analysis and display of genome-wide expression patterns
43. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells
44. Mechanisms for replicating DNA
45. The DNA replication fork in eukaryotic cells
46. Transcriptional activation of deoxyribonucleic acid polymerase α gene expression in MCF-7 cells by 17β-estradiol
47. Multiple phosphorylation sites of DNA polymerase α-primase cooperate to regulate the initiation of DNA replication in vitro
48. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice
49. Distinct roles of cdk2 and cdc2 in RP-A phosphorylation during the cell cycle
50. Cell-cycle-regulated phosphorylation of DNA replication factor A from human and yeast cells
51. Phosphorylation of replication protein A middle subunit (RPA32) leads to a disassembly of the RPA heterotrimer
52. Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions
53. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence
54. Implication of transcription factor E2F in regulation of DNA replication
55. Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle
56. Estrogenic impurities in labware
57. p-Nonyl-phenol: An estrogenic xenobiotic released from "modified" polystyrene
58. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture
59. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants
60. Loss of estrogen receptor β expression in malignant human prostate cells in primary cultures and in prostate cancer tissues
61. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO
62. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line
63. Timely toxicology
64. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution